Aptorum Group, DiamiR announce publication of microRNA biomarker study

Aptorum Group (APM) and DiamiR announced the publication of a paper by Giliberto, et. al. titled “Development of microRNA-Based Glioblastoma Biomarkers Using Blood Plasma Specimens” in Diagnostics. This study, conducted in collaboration with clinical researchers at the Perelman School of Medicine at the University of Pennsylvania, demonstrates the feasibility of detecting glioblastoma through a minimally invasive blood plasma test. The research identifies specific microRNA signatures in blood plasma that show significant promise as non-invasive biomarkers for glioblastoma diagnosis and monitoring.